Annual Drug Patent Expirations for CAROSPIR
Carospir is a drug marketed by Cmp Dev Llc and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug.
Drug patent litigation for CAROSPIR.
This drug has four patent family members in four countries.
The generic ingredient in CAROSPIR is spironolactone. Two suppliers are listed for this compound. Additional details are available on the spironolactone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com